Project
BMS CA 209-577
Automatically Closed · 2099 until 2019
Hess Dagmar, Kehl Jeanine, Müller Fiona
Type
Clinical Studies
Units
Status
Automatically Closed
Start Date
2099
End Date
2019
Financing
Industry
Labels
esophagus cancer
Brief description/objective
Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors (Phase I)